NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Historical Holders from Q1 2014 to Q3 2025

Symbol
NATR on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
17.7M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
14.5M
Holdings value
$225M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
120
Number of buys
76
Number of sells
-32
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
DIMENSIONAL FUND ADVISORS LP 5.2% $14.2M 914K Dimensional Fund Advisors LP 30 Sep 2025
BlackRock, Inc. 5.04% $13.8M 890K BlackRock, Inc. 30 Sep 2025
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 0.35% -97.2% $735K -$32.7M 64.2K -97.8% Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25 Jun 2025

Institutional Holders of NATURES SUNSHINE PRODUCTS INC - Common Stock (NATR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 14.5M $225M +$3.45M $15.52 120
2025 Q2 14.3M $211M -$12.7M $14.79 114
2025 Q1 15.2M $191M -$1.16M $12.55 95
2024 Q4 15.3M $224M -$516K $14.66 92
2024 Q3 15.3M $209M +$4.46M $13.62 88
2024 Q2 15M $226M -$3.09M $15.07 98
2024 Q1 15M $310M +$1.85M $20.77 106
2023 Q4 14.9M $258M +$8.91M $17.29 105
2023 Q3 14.4M $239M -$1.69M $16.57 91
2023 Q2 14.5M $198M +$115K $13.65 81
2023 Q1 11.6M $119M +$2.75M $10.21 77
2022 Q4 14.3M $119M -$402K $8.32 81
2022 Q3 14.4M $119M -$1.24M $8.24 75
2022 Q2 14.4M $154M -$512K $10.67 77
2022 Q1 14.2M $240M -$1.93M $16.82 92
2021 Q4 14.3M $265M +$2.25M $18.50 89
2021 Q3 14.3M $210M +$11M $14.65 77
2021 Q2 13.5M $235M +$979K $17.37 72
2021 Q1 13.5M $317M +$59.4M $19.96 72
2020 Q4 13.1M $196M +$1.07M $14.95 64
2020 Q3 15.4M $178M +$4.07M $11.57 67
2020 Q2 15.1M $136M +$180K $9.01 63
2020 Q1 15.1M $123M +$1.17M $8.13 57
2019 Q4 15M $134M +$1.61M $8.93 56
2019 Q3 14.7M $122M +$1.9M $8.29 57
2019 Q2 14.6M $136M +$994K $9.29 54
2019 Q1 14.5M $135M -$9.52K $9.29 51
2018 Q4 14.5M $118M -$26.2K $8.15 53
2018 Q3 14.5M $127M -$103K $8.75 54
2018 Q2 14.6M $136M +$91.2K $9.35 53
2018 Q1 14.5M $160M +$1.11M $11.00 52
2017 Q4 14.4M $167M +$1.41M $11.55 52
2017 Q3 14.2M $144M +$853K $10.15 54
2017 Q2 14.1M $187M +$2.19M $13.25 55
2017 Q1 14M $140M +$3.72M $10.00 52
2016 Q4 14M $210M +$1.54M $15.00 59
2016 Q3 13.8M $222M +$1.61M $16.00 56
2016 Q2 13.8M $131M -$164K $9.53 53
2016 Q1 13.8M $132M -$1.04M $9.60 53
2015 Q4 13.9M $141M +$358K $10.12 52
2015 Q3 13.9M $168M -$117K $11.98 57
2015 Q2 13.9M $191M -$1.56M $13.75 59
2015 Q1 14M $184M -$1.21M $13.12 63
2014 Q4 14.1M $208M +$40.5M $14.82 65
2014 Q3 11.3M $167M -$4.39M $14.83 65
2014 Q2 11.6M $196M +$785K $16.97 68
2014 Q1 11.5M $159M +$1.18M $13.78 64